Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.8K
Overview
51.8K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimising Haematopoietic Stem Cell Transplantation: Enhancing Myeloablation Sensitivity and Alleviating Anaemia Using Roxadustat (FG-4592).

Cell proliferation·2026
Same author

The role of impaired bone marrow Tregs in hematopoietic stem cell depletion for pediatric aplastic anemia probably involves immune privilege.

Blood research·2026
Same author

Correction: Prevalence, mutation distribution, and economic burden of thalassemia in China: a systematic review and regional analysis.

Archives of public health = Archives belges de sante publique·2026
Same author

A Novel <i>Col4a5</i>-G814fs Knock-In Mouse Model Reveals Phenotypic Heterogeneity Among Truncating <i>COL4A5</i> Mutations in X-Linked Alport Syndrome.

Genes·2026
Same author

[Genetic disease diagnosis and treatment in Shanghai: Survey and countermeasures for clinical genetics specialist training].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·2026
Same author

Reinforcement learning-based WSI diagnostic system for cervical squamous cell carcinoma and precancerous lesions.

Journal of translational medicine·2026

Related Experiment Video

Updated: Feb 8, 2026

Vaccines, APCs and Memory Cells
01:51

Vaccines, APCs and Memory Cells

51.8K

iPS cells produce viable mice through tetraploid complementation.

Xiao-yang Zhao1, Wei Li, Zhuo Lv

  • 1State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.

Nature
|August 13, 2009
PubMed
Summary

Researchers generated induced pluripotent stem (iPS) cells capable of producing live offspring via tetraploid complementation. This breakthrough demonstrates that iPS cells can achieve true pluripotency, similar to embryonic stem cells.

More Related Videos

Cancer Vaccines
01:30

Cancer Vaccines

1.1K

Related Experiment Videos

Last Updated: Feb 8, 2026

Vaccines, APCs and Memory Cells
01:51

Vaccines, APCs and Memory Cells

51.8K
Cancer Vaccines
01:30

Cancer Vaccines

1.1K

Area of Science:

  • Stem cell biology
  • Developmental biology
  • Genetics

Background:

  • Induced pluripotent stem (iPS) cells are generated by reprogramming somatic cells using transcription factors.
  • Current iPS cell technology faces challenges with slow reprogramming and inefficiency.
  • Previous iPS cells failed to produce live animals through tetraploid complementation, indicating incomplete pluripotency.

Purpose of the Study:

  • To generate iPS cell lines capable of full pluripotency.
  • To assess the developmental potential of iPS cells using tetraploid complementation.
  • To confirm if iPS cells can achieve pluripotency comparable to embryonic stem (ES) cells.

Main Methods:

  • Generation of novel iPS cell lines from mouse fibroblasts.
  • Utilizing the tetraploid complementation assay to evaluate pluripotency.
  • Comparing the developmental potential of generated iPS cells with established ES cells.

Main Results:

  • Successfully generated iPS cell lines that produced viable, fertile live-born progeny through tetraploid complementation.
  • Demonstrated that these iPS cells possess pluripotent potential nearly equivalent to in vivo or nuclear transfer-derived ES cells.
  • Confirmed the attainment of true pluripotency in iPS cells.

Conclusions:

  • iPS cells can achieve full pluripotency, rivaling that of ES cells.
  • Tetraploid complementation is a stringent assay for confirming pluripotency.
  • This advancement enables iPS cells as valuable tools for studying reprogramming and developmental potency.